Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

PROMIS and Mobility Evaluation in Sarcoma Patients

Evaluating the Implementation, Utility, and Clinical Importance of the Patient-Reported Outcome Measure Information System (PROMIS) in Sarcoma Patients: A Multi-Centered Prospective Cohort Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this is to validate the Patient-Reported Outcomes Measurement Information System (PROMIS) in sarcoma patients undergoing surgery, and to evaluate a novel smartphone app for collecting mobility data. The goals of the study include to: 1. Validate PROMIS as a patient outcome measure in sarcoma 2. Assess the effectiveness of a novel app for administering questionnaires and collecting mobility metrics 3. Compare PROMIS scores and mobility metrics to better evaluate recovery trajectories after surgery Participants will complete PROMIS questionnaires at regularly scheduled intervals using the smartphone app. Questionnaires will be completed pre-operatively and at 6 weeks, 12 weeks, 6 months, and 12 months post-operatively. Additionally, the app will passively track mobility metrics such as daily step count, stairs climbed, and gait parameters to compare with PROMIS scores.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥ 18 years - Diagnosis of bone sarcoma, soft tissue sarcoma, or giant cell tumor of bone - Tumors located in the pelvis, lower extremities, or upper extremities - Primary or recurrent disease - Undergoing operative tumor resection, including limb salvage surgery and amputation - Has an iPhone or Android phone - Speaks English Who Should NOT Join This Trial: - Metastatic bone tumor - Diagnosis of atypical lipomatous tumor or dermatofibrosarcoma protuberans - Currently pregnant or planning pregnancy within 6 months - Unwilling or unable to attend follow-up evaluations - Cognitive or communication barriers that impede completion of questionnaires Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of bone sarcoma, soft tissue sarcoma, or giant cell tumor of bone * Tumors located in the pelvis, lower extremities, or upper extremities * Primary or recurrent disease * Undergoing operative tumor resection, including limb salvage surgery and amputation * Has an iPhone or Android phone * Speaks English Exclusion Criteria: * Metastatic bone tumor * Diagnosis of atypical lipomatous tumor or dermatofibrosarcoma protuberans * Currently pregnant or planning pregnancy within 6 months * Unwilling or unable to attend follow-up evaluations * Cognitive or communication barriers that impede completion of questionnaires

Treatments Being Tested

PROCEDURE

Surgery

Any type of surgery performed to remove the primary tumor including resection, amputation, and bone stabilization.

Locations (4)

Mayo Clinic
Phoenix, Arizona, United States
Mayo Clinic
Rochester, Minnesota, United States
Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of Calgary
Calgary, Alberta, Canada
Mount Sinai Hospital, University of Toronto
Toronto, Ontario, Canada